BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1828751)

  • 1. Diabetes, cyclosporin nephrotoxicity, and serum creatinine concentration.
    McNally PG; Feehally J; Walls J
    Diabet Med; 1991 Apr; 8(3):289. PubMed ID: 1828751
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels.
    Bach JF; Feutren G; Noel LH; Hannedouche T; Landais P; Timsit J; Boitard C; Bougnères P; Boitard C; Grünfeld JP
    Transplant Proc; 1990 Jun; 22(3):1296-8. PubMed ID: 2349690
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrotoxicity of cyclosporin A in patients with newly diagnosed type 1 diabetes mellitus.
    Feldt-Rasmussen B; Jensen T; Dieperink H; Mandrup-Poulsen T; Nerup J; Bendtzen K; Andersen V; Kemp E; Leyssac PP
    Diabet Med; 1990 Jun; 7(5):429-33. PubMed ID: 2142040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term nephrotoxicity in liver transplantation.
    Poplawski S; Gonwa T; Goldstein R; Husberg B; Klintmalm G
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2469-71. PubMed ID: 2652809
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin-aldosterone system and renal function under cyclosporine A.
    Heering P; Westhoff A; Bach D; Sprenger KB; Passlick J; Helmchen U; Grabensee B
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):556-62. PubMed ID: 3291292
    [No Abstract]   [Full Text] [Related]  

  • 7. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
    Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin-A treatment for early insulin-dependent diabetes mellitus: first experience in Israel.
    Kisch ES; Yust I
    Isr J Med Sci; 1989 Jul; 25(7):414-6. PubMed ID: 2759840
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic cyclosporine-associated nephrotoxicity.
    Porter GA; Bennett WM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):204-9. PubMed ID: 3515689
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of cyclosporine of renal function in newly diagnosed diabetics.
    Stiller CR; Keown PA; Heinrichs D; Martell R; Dupre J; Jenner M; Rodger W; Wolfe B
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):202-8. PubMed ID: 4024248
    [No Abstract]   [Full Text] [Related]  

  • 11. Are serum creatinine levels adequate to identify the onset of chronic cyclosporine A nephrotoxicity?
    Mobb GE; Veitch PS; Bell PR
    Transplant Proc; 1990 Aug; 22(4):1708-10. PubMed ID: 2389439
    [No Abstract]   [Full Text] [Related]  

  • 12. What is cyclosporine nephrotoxicity?
    Myers BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1430-2. PubMed ID: 2652460
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversibility of cyclosporin nephrotoxicity after three months' treatment.
    Chapman JR; Griffiths D; Harding NG; Morris PJ
    Lancet; 1985 Jan; 1(8421):128-30. PubMed ID: 2857212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal changes associated with cyclosporine in recent type I diabetes mellitus.
    Rodier M; Ribstein J; Parer-Richard C; Mimran A
    Hypertension; 1991 Sep; 18(3):334-40. PubMed ID: 1889846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
    Pachon J; Lorber MI; Bia MJ
    Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
    Martin M; Packham D; Kingswood C; Cairns H; Khaghani A; Thompson D; Yacoub M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2516-7. PubMed ID: 3274553
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
    Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
    Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
    Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming early cyclosporine nephrotoxicity after liver transplantation.
    Burdick JF; Colombani PM; Pitt HA; Perler BA; Merritt WT; Crandall BC; Mitchell MC; Herlong HF; Williams GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2236-7. PubMed ID: 2652724
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
    Häyry P; von Willebrand E; Ahonen J
    Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.